Clinical Effect of Rebamipide on Chronic Gastritis
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To investigate the clinical effect of rebamipide in chronic gastritis patients. Patients with
chronic gastritis were randomly divided into the experimental group and the control group.
The experimental group were treated with rebamipide 0.1g tid and optimization of life style,
and the control group were only optimized their life style for 26 weeks. Upper
gastrointestinal endoscopy was performed in all patients to evaluate the severity of
gastritis by modified Lanza score (MLS) and the histology by the updated Sydney system before
and after treatment.